AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Treatment Recommendations for ILD in Rheumatic Diseases
This chapter discusses the new recommendations for the treatment of interstitial lung disease (ILD) in people with rheumatic diseases, including the use of Nintendenib and calcineurin inhibitors. It also explores the management of rapidly progressive ILD and the considerations for lung transplant evaluation.